Wed, October 2, 2024
[ 12:00 AM ] - WOPRAI
Tue, September 10, 2024
Mon, August 12, 2024
[ 12:00 AM ] - WOPRAI
Tue, August 6, 2024
Wed, July 31, 2024
[ 12:00 AM ] - WOPRAI
Thu, July 25, 2024
[ 12:00 AM ] - WOPRAI
Wed, June 26, 2024
[ 12:00 AM ] - WOPRAI
Thu, May 16, 2024
[ 12:00 AM ] - WOPRAI
Tue, May 14, 2024
[ 12:00 AM ] - WOPRAI
Tue, April 30, 2024
[ 12:00 AM ] - WOPRAI
Mon, April 22, 2024
[ 12:00 AM ] - WOPRAI
Thu, April 4, 2024
[ 12:00 AM ] - WOPRAI
Tue, March 12, 2024
Wed, March 6, 2024
[ 12:00 AM ] - WOPRAI
Thu, August 10, 2023
[ 12:00 AM ] - WOPRAI
Thu, May 18, 2023
[ 12:00 AM ] - WOPRAI
Mon, April 24, 2023
[ 12:00 AM ] - WOPRAI
Wed, March 22, 2023
[ 12:00 AM ] - WOPRAI
Fri, March 10, 2023
[ 12:00 AM ] - WOPRAI
Tue, February 28, 2023
[ 12:00 AM ] - WOPRAI
Sun, February 5, 2023
[ 12:00 AM ] - WOPRAI
Tue, January 3, 2023
[ 12:00 AM ] - WOPRAI
Mon, December 12, 2022
[ 12:00 AM ] - WOPRAI
Thu, November 17, 2022
[ 12:00 AM ] - WOPRAI
Mon, November 7, 2022
[ 12:00 AM ] - WOPRAI
Thu, July 7, 2022
Wed, June 22, 2022
[ 12:00 AM ] - WOPRAI
Wed, February 16, 2022
[ 12:00 AM ] - WOPRAI
Thu, October 8, 2020
[ 12:00 AM ] - WOPRAI
Mark Massaro Maintained (ADPT) at Strong Buy with Increased Target to $8 on, Oct 2nd, 2024
Mark Massaro of BTIG, Maintained "Adaptive Biotechnologies Corporation" (ADPT) at Strong Buy with Increased Target from $7 to $8 on, Oct 2nd, 2024.
Mark has made no other calls on ADPT in the last 4 months.
There is 1 other peer that has a rating on ADPT. Out of the 1 peers that are also analyzing ADPT, 0 agree with Mark's Rating of Hold.
This is the rating of the analyst that currently disagrees with Mark
- Rachel Vatnsdal of "JP Morgan" Maintained at Buy with Increased Target to $6 on, Friday, August 2nd, 2024
Contributing Sources